Risk factors for the recurrence of choroidal melanoma after the Ru-106 brachytherapy

Anna Bogdali; Bożena Romanowska-Dixon

Abstract

3/2015 vol. 117

Original paper

Risk factors for the recurrence of choroidal melanoma after the Ru-106 brachytherapy

Anna Bogdali ^{1, 2}

,

Bożena Romanowska-Dixon ^{1, 2}

Katedra Okulistyki Uniwersytetu Jagiellońskiego
Oddział Kliniczny Kliniki Okulistyki i Onkologii Okulistycznej Szpitala Uniwersyteckiego w Krakowie

Online publish date: 2021/06/01

View full text

AMA

Bogdali A, Romanowska-Dixon B. Risk factors for the recurrence of choroidal melanoma after the Ru-106 brachytherapy. Klinika Oczna / Acta Ophthalmologica Polonica. 2015;117(3):169-172.

APA

Bogdali, A., & Romanowska-Dixon, B. (2015). Risk factors for the recurrence of choroidal melanoma after the Ru-106 brachytherapy. Klinika Oczna / Acta Ophthalmologica Polonica, 117(3), 169-172.

Chicago

Bogdali, Anna, and Bożena Romanowska-Dixon. 2015. "Risk factors for the recurrence of choroidal melanoma after the Ru-106 brachytherapy". Klinika Oczna / Acta Ophthalmologica Polonica 117 (3): 169-172.

Harvard

Bogdali, A., and Romanowska-Dixon, B. (2015). Risk factors for the recurrence of choroidal melanoma after the Ru-106 brachytherapy. Klinika Oczna / Acta Ophthalmologica Polonica, 117(3), pp.169-172.

MLA

Bogdali, Anna et al. "Risk factors for the recurrence of choroidal melanoma after the Ru-106 brachytherapy." Klinika Oczna / Acta Ophthalmologica Polonica, vol. 117, no. 3, 2015, pp. 169-172.

Vancouver

Bogdali A, Romanowska-Dixon B. Risk factors for the recurrence of choroidal melanoma after the Ru-106 brachytherapy. Klinika Oczna / Acta Ophthalmologica Polonica. 2015;117(3):169-172.

Abstract

Risk factors for the recurrence of choroidal melanoma after the Ru-106 brachytherapy

Share

Integrated with

Editorial Policies